Jolande Boes

856 total citations
23 papers, 737 citations indexed

About

Jolande Boes is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, Jolande Boes has authored 23 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Epidemiology and 6 papers in Virology. Recurrent topics in Jolande Boes's work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (7 papers). Jolande Boes is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (7 papers). Jolande Boes collaborates with scholars based in Netherlands, Germany and France. Jolande Boes's co-authors include Claire J. P. Boog, Cornelis J.M. Melief, Petra de Vries, Paul Roholl, Albert D. M. E. Osterhaus, Willem Luytjes, Hidde L. Ploegh, Jacques Neefjes, Vincenzo Cerundolo and Martien C. M. Poelen and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Blood.

In The Last Decade

Jolande Boes

23 papers receiving 702 citations

Peers

Countries citing papers authored by Jolande Boes

Since Specialization

Citations

This map shows the geographic impact of Jolande Boes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolande Boes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolande Boes more than expected).

Fields of papers citing papers by Jolande Boes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolande Boes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolande Boes. The network helps show where Jolande Boes may publish in the future.

Co-authorship network of co-authors of Jolande Boes

This figure shows the co-authorship network connecting the top 25 collaborators of Jolande Boes. A scholar is included among the top collaborators of Jolande Boes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolande Boes. Jolande Boes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired Immune Response to Vaccination against Infection with Human Respiratory Syncytial Virus at Advanced Age 2014 ·Journal of Virology ·Teun Guichelaar, (unknown), Myra N. Widjojoatmodjo, Sylvia S. Reemers, Cécile A. C. M. van, (unknown), (unknown), Jolande Boes, Willem Luytjes	17
2	Infection-enhancing lipopeptides do not improve intranasal immunization of cotton rats with a delta-G candidate live-attenuated human respiratory syncytial virus vaccine 2013 ·Human Vaccines & Immunotherapeutics ·D. Tien Nguyen, Jolande Boes, Geert van Amerongen, (unknown), Selma Yüksel, Teun Guichelaar, Albert D. M. E. Osterhaus, Rik L. de Swart	1
3	A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats 2010 ·Virology Journal ·Myra N. Widjojoatmodjo, Jolande Boes, (unknown), (unknown), Paul Roholl, Willem Luytjes	47
4	Respiratory Syncytial Virus Infection of Monocyte-Derived Dendritic Cells Decreases Their Capacity to Activate CD4 T Cells 2005 ·The Journal of Immunology ·(unknown), Esther C. de Jong, (unknown), Mariska E. A. van Dijk, Paul Roholl, Jolande Boes, Willem Luytjes, Jan L. L. Kimpen, Grada M. van Bleek	103
5	In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components 2000 ·Vaccine ·Koert J. Stittelaar, Jolande Boes, Gideon Kersten, (unknown), Paul Mulder, Petra de Vries, Paul Roholl, Kristian Dalsgaard, Germie van den Dobbelsteen, Loek van Alphen, Albert D. M. E. Osterhaus	29
6	Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories 1995 ·Vaccine ·Ellen G. J. Hulskotte, Guus F. Rimmelzwaan, Jolande Boes, Marnix L. Bosch, Jonathan L. Heeney, Stephen Norley, Petra de Vries, Albert D. M. E. Osterhaus	7
7	Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines 1994 ·Vaccine ·Petra de Vries, Jonathan L. Heeney, Jolande Boes, (unknown), Ellen G. J. Hulskotte, Rob Dubbes, (unknown), Peter ten Haaft, Lennart Åkerblom, (unknown), Brør Morein, Steve Norley, Albert D. M. E. Osterhaus	23
8	Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. 1994 ·The Journal of Experimental Medicine ·Jonathan L. Heeney, Cécile A. C. M. van, Petra de Vries, Peter ten Haaft, Ńel Otting, Wim Koornstra, Jolande Boes, Rob Dubbes, Henk Niphuis, (unknown), Martin Cranage, Steve Norley, Margreet Jonker, Ronald E. Bontrop, Albert Osterhaus	65
9	Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. 1992 ·The Journal of Experimental Medicine ·Rob van Binnendijk, Carel A. van Baalen, Martien C. M. Poelen, Petra de Vries, Jolande Boes, Vincenzo Cerundolo, Albert D. M. E. Osterhaus, F. G. C. M. UytdeHaag	114
10	N-linked glycan modification on antigen-presenting cells restores an allospecific cytotoxic T cell response. 1990 ·The Journal of Experimental Medicine ·Jacques Neefjes, (unknown), Claire J. P. Boog, John D. Nieland, Jolande Boes, Cornelis J.M. Melief, Hidde L. Ploegh	24
11	Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen‐presenting cells 1989 ·European Journal of Immunology ·Claire J. P. Boog, Jacques Neefjes, Jolande Boes, Hidde L. Ploegh, Cornelis J.M. Melief	65
12	Dendritic Cells and Antigen Presentation in the Regulation of Cytotoxic T Lymphocyte Responses against Viruses and Transplantation Antigens 1988 ·Annals of the New York Academy of Sciences ·Cornelis J.M. Melief, Claire J. P. Boog, (unknown), Jolande Boes, Arie C. Voordouw, W. Martin Kast	8
13	Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses. 1988 ·The Journal of Immunology ·Claire J. P. Boog, Jolande Boes, C J Melief	31
14	Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses 1988 ·European Journal of Immunology ·Claire J. P. Boog, Jolande Boes, Cornelis J.M. Melief	40
15	Measurement of free, one-chain tissue-type plasminogen activator in human plasma with an enzyme-linked immunosorbent assay based on an active site-specific murine monoclonal antibody 1987 ·Blood ·Paul Holvoet, Jolande Boes, Désiré Collen	25
16	Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL. 1984 ·The Journal of Immunology ·M J Stukart, Jolande Boes, Cornelis J.M. Melief	6
17	Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants. 1984 ·The Journal of Immunology ·M J Stukart, Jolande Boes, Cornelis J.M. Melief	6
18	Immunity against moloney sarcoma virus in H-2Db mutant bm14 mice. Unimpaired tumor immunity despite absence of a virus-specific cytotoxic T-cell response 1984 ·International Journal of Cancer ·M J Stukart, Jolande Boes, Cornelis J.M. Melief	3
19	Mutations in H-2K b influence the specificity of alloreactive effector cells included in the repertoire of H-2D b -restricted cytotoxic T lymphocytes against Moloney leukemia virus 1983 ·Immunogenetics ·M J Stukart, Jolande Boes, Cornelis J.M. Melief	2
20	A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants. 1982 ·The Journal of Immunology ·M J Stukart, (unknown), Jolande Boes, Roger W. Melvold, Donald W. Bailey, C.J.M. Melief	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact